Birchview Capital’s 10x Genomics TXG Stock Holding History

Birchview Capital’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-59,000	Closed	-$962K	–	82
2025 Q4	$962K	Buy	+59,000	New	+$891K	0.56%	39
2025 Q3	–	Sell	-22,000	Closed	-$255K	–	77
2025 Q2	$255K	Sell	22,000 -28,000	-56%	-$255K	0.25%	55
2025 Q1	$437K	Hold	50,000	–	–	0.38%	36
2024 Q4	$718K	Buy	50,000 +20,000	+67%	+$316K	0.58%	25
2024 Q3	$677K	Hold	30,000	–	–	0.59%	26
2024 Q2	$584K	Hold	30,000	–	–	0.54%	27
2024 Q1	$1.13M	Hold	30,000	–	–	0.92%	24
2023 Q4	$1.68M	Buy	30,000 +9,000	+43%	+$392K	1.31%	18
2023 Q3	$866K	Buy	21,000 +9,000	+75%	+$468K	0.74%	24
2023 Q2	$670K	Buy	12,000 +2,000	+20%	+$108K	0.5%	31
2023 Q1	$558K	Hold	10,000	–	–	0.44%	32
2022 Q4	$364K	Buy	+10,000	New	+$327K	0.26%	39

Other funds holding TXG

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return